ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
Characterizing bidirectional transitions in mild cognitive impairment and post-reversion based on longitudinal neuroimaging and cognitive assessments.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Forecasting Alzheimer's disease progression via identity-preserved denoising diffusion generative adversarial network.NPJ digital medicine · 2026Article
- Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025).Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Review
- Characterizing bidirectional transitions in mild cognitive impairment and post-reversion based on longitudinal neuroimaging and cognitive assessments.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionCharacterizing transitions of cognitive state, including reversion from mild cognitive impairment (MCI) to normal cognition (NC) and subsequent cognitive stability or deterioration for post-reversion, has so far remained limited.
methodsUsing a retrospective cohort of subjects with an MCI diagnosis at study entry and at least two follow-up visits between 2005 and December 2022, we developed a functional multistate model framework to estimate longitudinal patterns of transition probabilities between different cognitive states.
resultsThe probability of reversion increased from 2% at baseline to a maximum of 8% by year 10 before gradual decline thereafter. For post-reversion, the probability of progression to MCI rose from 8% to 35.71% at Year 10 and subsequently stabilized. DISCUSSION: The instantaneous risk of MCI progressing was similar to the risk of re-progression to MCI for post-reversion. Post-reversion subjects remained at an increased risk of cognitive deterioration. HIGHLIGHTS: The instantaneous risk of MCI progressing to AD is similar to the risk of re-progression to MCI for post-reversion. The FMSM we developed effectively utilizes multiple longitudinal markers to reveal variable transition patterns between different cognitive states. Considering both spatiotemporal dimensions and sparse irregularities from longitudinal neuroimaging and neuropsychological scales, fMLFPCA and MVFPCA help to extract variation patterns, to capture detailed changes characterizing the multidimensional evolution patterns of MCI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.